📰 Andreaf Wainer News
Page 46 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
January 1, 2024
Curated Wealth Partners LLC lowered its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 5.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 10,432 shares of the healthcare product maker’s stock after selling 549 shares during the quarter. Curated Wealth Partners LLC’s holdings […]
January 1, 2024
Sustainable Insight Capital Management LLC boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 11.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 45,500 shares of the healthcare product maker’s stock after purchasing an additional 4,600 shares during the period. Abbott Laboratories comprises […]
December 31, 2023
Nixon Peabody Trust Co. purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 2,157 shares of the healthcare product maker’s stock, valued at approximately $209,000. Several other hedge […]
December 31, 2023
LFA Lugano Financial Advisors SA lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 53.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,442 shares of the healthcare product maker’s stock after selling 1,658 shares during the period. LFA Lugano Financial Advisors SA’s holdings in Abbott Laboratories were worth $140,000 at the […]
December 31, 2023
WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 29.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,700,000 shares of the healthcare product maker’s stock after […]
December 31, 2023
Nixon Peabody Trust Co. acquired a new position in Abbott Laboratories (NYSE:ABT – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,157 shares of the healthcare product maker’s stock, valued at approximately $209,000. Other hedge funds have also recently bought and sold […]
December 31, 2023
Cigna Investments Inc. New trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,495 shares of the healthcare product maker’s stock after selling 2,474 shares during the period. Cigna Investments Inc. New’s […]
December 30, 2023
Livforsakringsbolaget Skandia Omsesidigt cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.1% during the third quarter, HoldingsChannel reports. The institutional investor owned 26,017 shares of the healthcare product maker’s stock after selling 1,100 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Abbott Laboratories were worth $2,519,000 at the end of the […]
December 30, 2023
Charles Schwab Trust Co grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 84.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,953 shares of the healthcare product maker’s stock after purchasing an additional 10,079 shares during […]
December 30, 2023
Oak Family Advisors LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,503 shares of the healthcare product maker’s stock after selling 449 shares during the quarter. […]